Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinaldo Pellicano

Showing results (51-60 of 399) with videos related to

Pageof 40
Sort By:
European Journal of Gastroenterology & Hepatology|December 24, 2014
Helicobacter pylori and cirrhosis: any missing data in the meta-analysis?Rinaldo Pellicano, Sharmila Fagoonee
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|February 3, 2016
Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015"Sharmila Fagoonee, Rinaldo Pellicano
Minerva Gastroenterology|April 19, 2022
Why gastrointestinal bleeding could occur in COVID-19 patients?Maria Staiano, Rinaldo Pellicano
Minerva Medica|May 15, 2020
COVID-19 brings the world economy to its kneesIndurlall Fagoonee, Rinaldo Pellicano
Panminerva Medica|July 11, 2022
High acceptance rate of SARS-CoV-2 vaccination in alcohol use disorders patientsGianni Testino, Rinaldo Pellicano
Minerva Medica|April 14, 2018
Warning for cardiologists: alcohol is not suitable for cardiovascular preventionGianni Testino, Rinaldo Pellicano
Hepatology (Baltimore, Md.)|June 12, 2018
Upper GI Bleeding in Cirrhotic Patients: Which Method to Search for Helicobacter Pylori Infection?Rinaldo Pellicano, Marilena Durazzo
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|December 15, 2015
One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015?Rinaldo Pellicano, Sharmila Fagoonee
Scandinavian Journal of Urology and Nephrology|May 18, 2010
Comment and reply on "Helicobacter pylori seroprevalence in patients with chronic prostatitis: a pilot study"Rinaldo Pellicano, Sharmila Fagoonee
Digestive Diseases and Sciences|April 13, 2007
Helicobacter pylori and coronary artery disease: which is the better target population?Rinaldo Pellicano, Mario Rizzetto
Pageof 40

Showing results (51-60 of 399) with videos related to

Sort By:
Pageof 40
European Journal of Gastroenterology & Hepatology|December 24, 2014
Helicobacter pylori and cirrhosis: any missing data in the meta-analysis?Rinaldo Pellicano, Sharmila Fagoonee
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|February 3, 2016
Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015"Sharmila Fagoonee, Rinaldo Pellicano
Minerva Gastroenterology|April 19, 2022
Why gastrointestinal bleeding could occur in COVID-19 patients?Maria Staiano, Rinaldo Pellicano
Minerva Medica|May 15, 2020
COVID-19 brings the world economy to its kneesIndurlall Fagoonee, Rinaldo Pellicano
Panminerva Medica|July 11, 2022
High acceptance rate of SARS-CoV-2 vaccination in alcohol use disorders patientsGianni Testino, Rinaldo Pellicano
Minerva Medica|April 14, 2018
Warning for cardiologists: alcohol is not suitable for cardiovascular preventionGianni Testino, Rinaldo Pellicano
Hepatology (Baltimore, Md.)|June 12, 2018
Upper GI Bleeding in Cirrhotic Patients: Which Method to Search for Helicobacter Pylori Infection?Rinaldo Pellicano, Marilena Durazzo
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|December 15, 2015
One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015?Rinaldo Pellicano, Sharmila Fagoonee
Scandinavian Journal of Urology and Nephrology|May 18, 2010
Comment and reply on "Helicobacter pylori seroprevalence in patients with chronic prostatitis: a pilot study"Rinaldo Pellicano, Sharmila Fagoonee
Digestive Diseases and Sciences|April 13, 2007
Helicobacter pylori and coronary artery disease: which is the better target population?Rinaldo Pellicano, Mario Rizzetto
Pageof 40